BT8009: A Bicycle Toxin Conjugate Targeting Nectin-4 for the Treatment of Solid Tumours

Time: 11:40 am
day: Track B - Day 1 AM


  • BT8009 binds to Nectin-4 with high affinity and selectivity
  • BTC format allows rapid tumour penetration and delivery of cytotoxic payload MMAE
  • A Phase I/II trial of BT8009 is underway in patients with advanced solid tumours associated with Nectin-4 expression